Patent · US Active

Opioid agonist antagonist combinations

US9211293B2 · kind B2 · utility

41Cited by

37References

19Claims

0Family size

Assignee

Alkermes Pharma Ireland Limited · IE

Inventors

Daniel R. Deaver · Franklin, US
Elliot Ehrich · Lincoln, US

Key dates

Filing date	Dec 17, 2012
Grant date	Dec 15, 2015
Priority date	—
Expiry date	Dec 17, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates a composition comprising an opioid agonist and Compound-1:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.